FIELD: medicine.
SUBSTANCE: present invention relates to a method of treating cystic fibrosis using the compound of formula .
EFFECT: technical result: new efficient method of treating or lessening the severity of cystic fibrosis in a patient using said compound.
4 cl, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
HETEROCYCLIC MODULATORS OF ATP-BINDING CARTRIDGE TRANSPORTER | 2006 |
|
RU2463303C2 |
HETEROCYCLIC MODULATORS OF TRANSPORTERS OF AN ATP-BINDING CASSETTE | 2016 |
|
RU2765714C2 |
MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | 2008 |
|
RU2512682C2 |
MODULATORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE | 2007 |
|
RU2459821C2 |
METHODS AND INTERMEDIATE COMPOUNDS | 2010 |
|
RU2531588C2 |
MODULATORS OF ATP-BINDING CARTRIDGE TRANSPORTERS | 2012 |
|
RU2640420C2 |
PPAR-SUPPORTING COMPOUNDS FOR TREATING METABOLIC DISEASES | 2014 |
|
RU2687490C2 |
PPAR-SUPPORTING THIAZOLIDINEDIONES AND THEIR COMBINATIONS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | 2010 |
|
RU2570424C2 |
THIAZOLIDINEDIONE SALTS WITH REDUCED AFFINITY TO PPAR FOR TREATMENT OF METABOLIC DISORDERS | 2010 |
|
RU2564661C2 |
METHODS AND INTERMEDIATE PRODUCTS | 2006 |
|
RU2446171C2 |
Authors
Dates
2017-01-23—Published
2012-06-05—Filed